Want to see DVA full AI Analyst Report?
Treatment Days
Indicates the total number of days treatments are provided, reflecting the company’s capacity utilization and potential revenue generation.
Treatment days have been remarkably stable for years, with only small seasonal Q1 dips (notably Mar‑2025 and Mar‑2026). Management is banking on utilization and productivity — not big increases in patient days — to drive the guidance raise (treatments per normalized day expected to rise), so earnings upside is more operational than volume-driven. Key risks: softer admits and ACA mix shifts could negate these modest utilization gains, so track admit trends and RPT trajectory over the next two quarters.
DVA Treatment Days
| Date | Treatment Days |
|---|---|
| Jun 30, 2026 | 78.00 |
| Mar 31, 2026 | 76.50 |
| Dec 31, 2025 | 79.50 |
| Sep 30, 2025 | 79.00 |
| Jun 30, 2025 | 78.00 |
| Mar 31, 2025 | 76.70 |
| Dec 31, 2024 | 79.00 |
| Sep 30, 2024 | 79.00 |
| Jun 30, 2024 | 78.00 |
| Mar 31, 2024 | 78.00 |
| Dec 31, 2023 | 78.00 |
| Sep 30, 2023 | 79.00 |
| Jun 30, 2023 | 78.00 |
| Mar 31, 2023 | 77.00 |
| Dec 31, 2022 | 79.00 |
| Sep 30, 2022 | 79.00 |
| Jun 30, 2022 | 78.00 |
| Mar 31, 2022 | 77.00 |
| Dec 31, 2021 | 79.00 |
| Sep 30, 2021 | 79.00 |
| Jun 30, 2021 | 78.00 |
| Mar 31, 2021 | 77.00 |
| Dec 31, 2020 | 79.00 |
| Sep 30, 2020 | 79.00 |
| Jun 30, 2020 | 78.00 |
| Mar 31, 2020 | 77.60 |
